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Abstract
Aspergillus fumigatus is the most commonly encountered mold pathogen of humans, predominantly infecting the
respiratory system. Colonization and penetration of the lung alveolar epithelium is a key but poorly understood step in the
infection process. This study focused on identifying the transcriptional and cell-signaling responses activated in A549
alveolar carcinoma cells incubated in the presence of A. fumigatus wild-type and DPrtT protease-deficient germinating
conidia and culture filtrates (CF). Microarray analysis of exposed A549 cells identified distinct classes of genes whose
expression is altered in the presence of germinating conidia and CF and suggested the involvement of both NFkB and MAPK
signaling pathways in mediating the cellular response. Phosphoprotein analysis of A549 cells confirmed that JNK and ERK1/
2 are phosphorylated in response to CF from wild-type A. fumigatus and not phosphorylated in response to CF from the
DPrtT protease-deficient strain. Inhibition of JNK or ERK1/2 kinase activity substantially decreased CF-induced cell damage,
including cell peeling, actin-cytoskeleton damage, and reduction in metabolic activity and necrotic death. These results
suggest that inhibition of MAPK-mediated host responses to treatment with A. fumigatus CF decreases cellular damage, a
finding with possible clinical implications.
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Introduction
Fungi belonging to the genus Aspergillus are important
opportunistic pathogens of immunocompromised patients. Asper-
gillus fumigatus is the main causative agent of aspergillosis. Invasive
pulmonary aspergillosis (IPA) is the most severe form of the
disease, in which inhaled Aspergillus spores invade and colonize the
lungs, and subsequently spread to other organs through the
bloodstream [1]. Mortality rates in patients with IPA, including
those receiving intensive antifungal treatment, remain unaccept-
ably high (50 to 70%) [2,3].
A. fumigatus is responsible for approximately 90% of human
Aspergillus infection. It reproduces asexually by producing prodi-
gious numbers of spores, which are disseminated by air currents.
Environmental studies indicate that all humans inhale at least
several hundred A. fumigatus conidia per day [4]. Due to their small
size (2–3.5 mm), A. fumigatus conidia often surmount the barrier
posed by the ciliary action of the airway epithelium and directly
enter the alveolar sacs. In healthy alveoli, the epithelial surface
consists mainly of type I and type II cells (pneumocytes). Type I
cells are extremely thin and flat and cover about 95% of the
alveolar surface. Type II cells are cuboid and rich in secretory
granules. Below the alveolar epithelium are the basal lamina and
the underlying capillary endothelium. In neutropenic patients, this
delicate structure is a convenient and rapidly penetrable portal for
infection.
Following inhalation and binding to the alveolar epithelium, the
conidia germinate. Most of the adherent conidia are normally
eliminated by innate immune mechanisms, notably by resident
alveolar macrophages that phagocytose and kill the conidia and
recruited neutrophils that destroy both conidia and hyphae by
secretion of toxic reactive oxygen intermediates and the formation
of neutrophil extracellular traps (NETs) [5,6,7]. In immunocom-
promised patients lacking these defenses, conidial germination and
hyphal growth occur, frequently leading to dissemination of
aspergillosis [1,8].
Major advances have been recently made in deciphering the
interaction of A. fumigatus with macrophages and neutrophils.
These cells identify A. fumigatus surface antigens through binding to
Toll-like receptors (TLR2 and TLR4) [9,10,11] and dectin 1
receptors [12,13,14,15]. This recognition initiates a complex
signaling cascade, including activation of MAPK signaling, the
NFkB pathway, and the subsequent release of proinflammatory
cytokines such as IL6, TNF-a and IL1b [9,10,16].
In contrast, progress in identifying the molecular mechanisms of
epithelial lung cell infection has been slow. Cell-culture models
and in-vitro binding assays have demonstrated that A. fumigatus
conidia bind to A549 type-II-like lung epithelial cells and to
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binding to the cells, about 3 to 6% of infecting conidia are
internalized into actin-coated vacuoles through actin- and tubulin-
dependent mechanisms [20]. Externally bound conidia germinate
and begin hyphal growth, causing cytokine release, cell rounding,
detachment and necrosis in the infected cells [21,22,23]. Addition
of A. fumigatus culture filtrate (CF) to the cells results in a similar
cellular response, suggesting that factors secreted by the fungus are
involved. Borger et al. [21] showed that CF secreted by A. fumigatus
induces the production of proinflammatory cytokines (IL6 and
IL8) and activation of NFkB in A549 cells. Interestingly, these
responses are blocked by the addition of serine-protease inhibitors
to the CF, indicating serine-protease dependency. Subsequently,
Kauffman et al. [24] demonstrated that proteases present in fungal
extracts from both A. fumigatus and other non-aspergillus fungi
interact with A549 cells, leading to morphological changes, cell
desquamation, and induction of proinflammatory cytokines. We
have demonstrated that secreted A. fumigatus proteases are
responsible for depolymerization of the actin cytoskeleton of
A549 cells, destruction of focal adhesions and subsequent loss of
adhesion, leading to cell rounding and death [25]. Recently, we
and others have generated a protease-deficient strain of A. fumigatus
in which the transcription factor PrtT, a positive regulator of
secreted proteases, was deleted [26,27]. CF derived from this
mutant strain shows low to undetectable levels of protease activity.
In this work, we further characterized the effects of secreted A.
fumigatus proteases on exposed A549 cells. We elucidated the
genome-wide transcriptional response and the changes in protein
kinase phosphorylation patterns of lung cells in response to wild-type
(WT) and DPrtT protease-deficient germinating conidia and CFs,
and identified key cellular signaling proteins affecting their response.
Materials and Methods
Microarray experiments
A549 cells were grown at a density of 1610
6 cells/100 mm dish,
and cultured in serum-free minimal essential medium (MEM) for
16 to 18 h before treatment. Cells were incubated for 8 h with WT
A. fumigatus conidia (AF293), DPrtT protease-deficient conidia
(AF293 background), A. fumigatus CF, and DPrtT protease-deficient
CF. Total RNA was prepared from treated and control uninfected
A549 cells with RNeasy columns (Qiagen, Hilden, Germany) as
recommended by Affymetrix (Santa Clara, CA). Total RNA was
reverse-transcribed (Agilent Technologies, Santa Clara, CA) and
the resulting cDNA was used as a template for in-vitro transcription
with biotin-labeled oligonucleotides. Following fragmentation, it
was hybridized to the array as directed by the manufacturer
(Affymetrix). We used two different arrays, the GeneChip Human
Genome U133A 2.0 array and later, the Human Gene 1.0 ST
array offering whole-transcript coverage. Each of the 28,869 genes
is represented on the array by approximately 26 probes spread
across the full length of the gene. Three independent biological
experiments were performed. All data is MIAME compliant and
the raw data has been deposited at the NCBI GEO website, a
MIAME compliant database, as detailed on the FGED Society
website (GEO accession numbers GSE 24983-5).
Microarray computational analysis
The expression profiles were analyzed using EXPANDER, a
general microarray analysis software [28]. EXPANDER supports
all analytical steps, including normalization and filtering, gene
clustering and differential expression analysis, and various
statistical tests for gene group analysis including functional
enrichment and transcription factor binding site enrichment.
In preprocessing of the microarray data, following hierarchical
clustering of the samples, three outliers were removed (see Text
S1), and filtering of low-intensity probes left 14,831 and 14,653
genes in the CF and conidia experiments, respectively.
Differential genes were identified between each two sets of
conditions, and for each set GO functional enrichment was evaluated
using TANGO (FDR/False Discovery Rate ,0.1) and promoter
signals were evaluated using PRIMA (p-value ,10
24, uncorrected).
Finally, enrichment for KEGG pathways was performed using a
hypergeometric test (p-value ,10
24, uncorrected). See supplemental
material for further details.
Semi-quantitative PCR validation of key genes identified
in the microarray analysis
RNA was isolated from 10
6 A549 cells with TRIzol (Sigma
Chemical Co., St. Louis, MO) and treated with DNase (Ambion,
Austin, TX) following the manufacturer’s protocols. RNA was
used to synthesize cDNA using AffinityScript reverse transcriptase
according to the manufacturer’s protocols. For RT-PCR, A549
cells were cultured on 10-cm tissue-culture plates for 24 h in
Dulbecco’s modified Eagle’s medium (DMEM); 1 ml of TRI
Reagent (Molecular Research Center, Cincinnati, OH) was added
to each plate, and RNA was isolated from approx 2 million cells
according to the protocol supplied by the manufacturer. Total
RNA (1 mg in a total volume of 12 ml) was denatured at 70uC for
10 min and used for reverse transcription as described by the
standard protocol (Stratagene). PCR amplification was performed
with downstream primers specific for the human IL8 and MCP1
genes and the housekeeping gene b-actin. PCR products were
analyzed by gel electrophoresis. Analysis was performed on
samples collected during the logarithmic phase of the PCR. Each
PCR was independently performed three times on the same RNA
sample. Control DNase-treated RNA samples that lacked reverse
transcriptase were PCR-amplified in parallel and showed no
amplified fragments. Densitometric analysis was carried out with
the TINA 2.0 software package (Molecular Dynamics Inc.,
Sunnyvale, CA). Densitometric values were normalized by
calculating the ratio between the experimental point and actin
expression. Final values were derived by calculating the ratio
between the normalized experimental and reference points.
Statistical analysis was performed using Student’s two-tailed t test.
Preparation of fungal CF
Conidia were collected in a 0.01% (vol/vol) Tween 80 (Sigma)
solution, washed twice in phosphate-buffered saline (PBS), and
resuspended at a concentration of 1610
5 conidia/ml in 100 ml of
MEM containing 10% (wt/vol) fetal calf serum (FCS; Biological
Industries, Beit-Haemek, Israel). The FCS was heated for 30 min at
66uC to inactivate endogenous proteases.Fungal cultures were grown
in an orbital incubator for 48 h, 37uC at 200 rpm, conditions which
have previously been shown to produce a toxic CF [26]. CF contains
the entire range of molecules secreted by the fungus, including low
molecular-weight secondary metabolites and secreted proteins. To
prepare WT-CF devoid of proteolytic activity, the CF was heated at
70uC for 30 min. This treatment reduced the proteolytic activity of
the CF (as measured by the azocasein assay) to undetectable levels.
Western blot analysis for endogenous JNK, ERK1/2, p38
and c-jun phosphorylation
A549 cells were treated for various times with A. fumigatus CF, or
1610
7 A. fumigatus conidia (AF293 and DPrtT strains). Subsequently,
cells were trypsinized and centrifuged at 500 g for 5 min. Cells
were washed in PBS and incubated with 60 ml lysis buffer (50 mM
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acid, 1% wt/vol NP-40, 1 mM sodium orthovanadate, and
0.2% wt/vol protease inhibitor cocktail; Sigma-Aldrich) for 1 h on
ice. The protein concentration of the sample was determined by
BioRad DC Protein Assay (Bio-Rad Laboratories Inc., Hercules, CA).
Protein extracts were mixed with sample buffer consisting of 60 mM
Tris, pH 6.8, 3% (wt/vol) sodium dodecyl sulfate (SDS), 10% (vol/vol)
glycerol, 5% (vol/vol) 2-mercaptoethanol, and 0.05% (wt/vol)
bromophenol blue, and boiled for 5 min. Protein samples (120 mgo f
whole-cell lysate) were subjected to SDS-PAGE, and proteins were
transferred to nitrocellulose filters (Hybond, Amersham Pharmacia
Biotech AB, Uppsala, Sweden). The filters were blocked for 1 h at
room temperature with 3% (wt/vol) BSA (bovine serum albumin) in
TBS (Tris-buffered saline) with 0.1% Tween-20 and incubated
o v e r n i g h ta t4 uC with the following primary antibodies: anti-dipho-
sphorylated ERK antibody (Thr183/Tyr185) (Sigma) 1:10,000, anti-
ERK MAPK (BioSource, Rockville, MD) 1:1000, and anti-p-SAPK/
JNK (Thr183/Tyr185), anti-SAPK/JNK, anti-p-p38 (Thr180/
Tyr182), anti-p38 and anti c-jun (all at 1:1000; Cell Signaling, Beverly,
MA). Primary antibodies were detected by horseradish peroxidase-
conjugated secondary antibodies (1:10,000; Jackson ImmunoResearch
Laboratories Inc., West Grove, PA). The targeted protein was revealed
by enhanced chemiluminescence (ECL). The membrane was
incubated with an ECL solution (Biological Industries) and exposed
to ECL film (Eastman Kodak, Rochester, NY) to visualize specifically
labeled proteins. The resulting exposed films were then analyzed by
densitometry. All experiments were performed at least three times.
MAPK inhibitor study
Cells were plated at a density of 1610
6/100 mm dish (for
western blot analysis), or at 5610
4/well in a 96-well dish (for XTT
viability staining and hemacolor staining) and cultured in serum-
free MEM for 16 to 18 h before treatment. Cells were treated with
the specified MAPK inhibitors for 2 h, washed and exposed to
A. fumigatus CF for the indicated times. Western blot analysis was
performed as described above. The following MAPK inhibitors
were used in this study: (i) FR180204 (50 mM, Calbiochem, San
Diego, CA), an ERK1/2 inhibitor [11], (ii) SP600125 (25 mM,
Sigma), a selective and reversible inhibitor of JNK, and (iii)
SB203580 (25 mM, Calbiochem), a specific inhibitor of p38. For
XTT viability assays and microscopy, A. fumigatus CF was remov-
ed, and the cells were washed twice with PBS and evaluated for
cytotoxicity with the XTT assay (see below) or stained with
hemacolor. For hemacolor staining, cells were fixed in methanol,
stained with hemacolor reagent (Merck, Darmstadt, Germany).
Azocasein assay for proteolytic activity of CFs
General proteolytic activity was measured by azocasein assay
[25,26]. Azocasein (5 mg/ml; Sigma) was dissolved in 50 mM
Tris-HCl (pH 7.5), 0.2 M NaCl, 5 mM CaCl2, 0.05% (wt/vol)
Triton X-100, and 0.01% (wt/vol) sodium azide. A 400-ml aliquot
of this solution was mixed with 100 ml of CF. After overnight
growth at 37uC, 150 ml of 20% (vol/vol) trichloroacetic acid was
added. After 30 min at room temperature, the tubes were centri-
fuged at 16,000 g for 3 min, and the pellets were discarded. The
supernatant was mixed with an equal volume of 1 M NaOH, and
absorption of the liberated dye was measured at 436 nm.
XTT(2,3-bis-[2-methoxy-4-nitro-5-sylfophenyl]-2H-
tetrazolium-5-carboxanilide, disodium salt) cell viability
assay
A549 cells were grown in 96-well cell-culture plates to 80%
confluency. CF was added to the cells following preincubation
with the MAPK inhibitors. After incubation, XTT reagent
(Biological Industries) was added, and the colorimetric assay was
performed as specified by the manufacturer. Absorbance (optical
density at 490 nm) was read on an ELISA reader (Spectra MAX
340; Molecular Devices, Sunnyvale CA). Results are representa-
tive of three independent experiments performed in triplicate and
are expressed as mean 6 SD (error bars) of three replicates.
Flow cytometry analysis of CF-induced apoptosis/
necrosis in A549 cells
A549 cells were grown in DMEM with 10% FCS in 6-well
plates at a concentration of 5610
5/well. The growth medium was
replaced with CF and the cells were incubated for various times.
The CF was removed and the cells were washed twice with PBS.
Untreated WT and protease-deficient CF-treated adherent cells
were detached with 0.5% (wt/vol) EDTA (Sigma-Aldrich), washed
twice, and labeled with annexin V/propidium iodide [29] (Bender
MedSystems, MedSystems Diagnostics GmbH, Vienna, Austria)
according to the manufacturer’s recommendations. Analysis of
apoptosis was performed with a FACSort flow cytometer (Becton,
Dickinson and Company, Franklin Lakes, NJ). Results were
analyzed with FlowJo software.
Actin staining
A549 cells were fixed for 30 min at room temperature in PBS
containing 3% (vol/vol) paraformaldehyde and permeabilized
with 0.5% (wt/vol) Triton X-100 for 3 min. Cells were then
incubated for 40 min at room temperature with phalloidin
fluorescein isothiocyanate (FITC) (for actin staining) diluted 1:75
(Molecular Probes, Eugene, ORE), washed three times in PBS and
viewed in a Zeiss confocal laser scanning microscope (CLSM 410)
equipped with a 25-mW krypton-argon laser and a 10-mW
helium-neon laser (543 nm).
Statistical analysis
All experiments were independently performed at least three
times. Unless otherwise stated, a representative experiment is
displayed. Error bars denote SDs.
P-values were calculated by Student’s t test or ANOVA.
Differences were considered to be statistically significant when
p,0.05.
Results
Microarray analysis
We have previously shown that exposure of A549 cells to
A. fumigatus germinating conidia or CF results in protease-
dependent actin-cytoskeleton destruction, cell rounding, peeling
and death [25]. To better understand these processes at the
molecular level, we determined changes in gene expression in
treated cells by microarray analysis. A549 cells were incubated in
the presence of WT or DPrtT conidia, or WT CF or DPrtT CF
lacking protease activity for 8 h. This time point was selected
because we previously demonstrated that at this stage, WT
germinating conidia or CF induce partial actin-cytoskeleton
depolymerization and cell rounding, without killing the cells
[25]. We found minor differences between the transcriptional
responses of cells infected with WT or DPrtT conidia (see Text S1).
WT germinating conidia significantly increased the mRNA levels
of 115 probes (94 genes) relative to untreated cells. These genes
were categorized by the Expander program and included those
encoding cytokines (p=1E-9), signal transduction pathways
(p=1E-5) and in particular, the MAPK cascade (p=1.17E-10)
and transcription factors (p=1.9E-7) (Table 1 and Table S1, all
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indicated significant enrichment for genes containing NFkB
(p=4.25E-6) and MAPK-activated SRF (p=3.86E-5) transcrip-
tion factor binding sites (Table S2). The mRNA expression level of
one gene was significantly decreased by conidial infection relative
to untreated cells (NDUFB7, Table S3). Together, results
suggested that conidial infection induces a strong protective
response in infected A549 cells, characterized by the activation of
genes participating in intracellular signaling pathways and the
secretion of inflammatory cytokines. Worth noting is the modest
number of genes that responded to A. fumigatus conidial exposure,
unlike the response observed for WT CF which significantly
increased the mRNA levels of 357 probes (291 genes) relative to
untreated cells (Table S4). These included genes encoding proteins
involved in (Table 2) signal transduction and in particular MAPK
signaling (MAPKKK cascade p=1.46E-7) and cytoskeletal
regulation (p=1.8E-5), transcription factor activity (p=3.19E-8),
including negative regulators of transcription. There was signifi-
cant enrichment for genes containing E2-F1 (p=9.35E-7), AP-2a
(p=1.15E-5) and Sp1 (p=3.21E-6) binding sites (Table S5). These
transcription factors have been shown to induce cell-cycle arrest
and apoptosis [30,31].
CF significantly decreased the mRNA levels of 396 probes (324
genes) relative to untreated cells (Table S6). These included genes
encoding proteins involved in amino acid nitrogen and lipid
metabolism processes (cellular amino acid and derivative meta-
bolic process, p=4.45E-21, lipid metabolic process, p=9.38E-9
and nitrogen compound metabolic process, p=6.92E-10), sug-
gesting a general shutdown of energy-intensive metabolic processes
(Table 3).
A comparison of the effects of WT CF and DPrtT CF on A549
gene expression showed that the former significantly increased the
mRNA levels of 259 probes (226 genes) relative to the latter (Table
S7). These included genes encoding proteins involved in cell-cycle
control (cell cycle, p=3.66E-39), and in particular regulation of
microtubules (microtubule cytoskeleton, p=1.86E-20) and the
unfolded protein response (UPR) (response to unfolded protein,
p=4.65E-6, Table 4), which suggests that the WT-CF-treated cells
could be modulating cell cycling and protein synthesis and folding
in response to protease activity or other PrtT-dependent secreted
proteins in the WT filtrate. There was significant enrichment in
genes containing binding elements for the transcription factor NF-
Y( p=4.79E-19, 40/75 genes, Table 4, underlined). The mRNA
levels of 517 probes (473 genes) were significantly reduced in WT-
CF-treated cells relative to those treated with DPrtT CF (Table S8).
These included genes encoding proteins involved in signal
transduction (regulation of cell communication, p=4.35E-15 and
regulation of small GTPase-mediated signal transduction,
p=1.12E-12) and in particular vesicle trafficking (p=1.84E-6),
transporter activity (p=1.81E-5) and actin-cytoskeleton dynamics
(cytoskeleton organization, p=4.95E-7), suggesting that these
functions are impaired by the protease activity in the WT CF.
There was significant enrichment in genes containing binding
elements for the transcription factor MOVO-B (p=1.12E-5,
Table 5, underlined) which is involved in promoting angiogenesis
[32].
We independently validated the microarray results for two key
cytokines, IL8 and MCP1, by RT-PCR analysis (Fig. 1).
Microarray analysis showed a 103-fold increase in IL8 mRNA
levels in response to conidial infection, and a 4-fold increase in
Table 1. Genes upregulated in response to wild-type conidial infection.
GENE CATEGORIES Genes Up regulated by wild-type conidial infection
Cytokine signaling and inflammation (GO:0005125) AREG, MCP1 (CCL2), CCL20, CXCL1, CXCL2, CXCL3, IL6, IL8, LIF, PTGS2, VEGF
Signal Transduction (GO:0007166) ADM, AKAP12, BIRC3, CTGF, DUSP1
MK, DUSP4
MK, DUSP5
MK, DUSP6
MK, DUSP8
MK,
FST, GEM, GPRC5A, PLAUR, RGS2, SOCS5, SOCS6, SPRY4
MK, STC1,TRIB1
MK
Transcription factor activity (GO:0003700) ATF3, BCL3, BHLHE40, CBFB, EGR1, FOS, FOSL1, FOXO1, JUN, JUNB, KLF5, KLF6
C,
MAFF, NFkBIA, NAB1, NFIL3, NRG1 NR4A1, NR4A2, NR4A3, SERTAD2, TNFAIP3
doi:10.1371/journal.pone.0017509.t001
Table 2. Genes upregulated in response to WT CF treatment.
GENE CATEGORIES A549 genes upregulated in response to WT CF treatment
Cytokine signaling (GO:0005125) CCL2, HRH1, IL8, IL1RL1, IL6R, IL27RA
Signaling PW
(GO:0007242)
ARHGDIA, BAIAP2
C, BDNF
MK, CAV1
MK, CCND1, CCNE2, DCBLD2, DUSP6
MK, DVL1, EPHA2, EREG, E2R
C,
F2R, FAT1
C, FAS, FGF2, FGFBP1, FGFR1
MK, FST, FSTL3, GTSE1
MK, ITGA3
C, KRTI5
C, MAP3K2
MK, MAP4K5
MK,
MAPKAP
MK, NRG1, NRP2, OXTR, PAK2
C, PLAUR, PTHLH, PLCL2, P2RY2, RGS20, RAB35
C, RALA
C, RAP2A
C,
RHOB
C, RHOF
C, SERPINE1, SFN, SGK1, SFRP1, SMURF2, SOCS2, SOCS5, SOD2, SOS1, TAOK
MK,
TGFA, TGFB2, THBD, TMX1, TNFRSI9, TRIB1
MK, VEGCF
Transcription factor activity
(GO:0003700)
ARNTL2, CNOT3, CSRNP2, ETS, ETS2, FOSL1, FOSL2, JUN, KLF4, KLF5, KLF6
C, LMO4,
MAFF, MDFIC, MSX1, MYBL1, NFKB2
I, NFKB1A, NFKBIE, NKX3-1, NPAS2, NR5A2,
PPARG, RELB, SBNO2, SOX9, TBX3, WWTR1, ZBTB1, ZFP36L1, ZNF174, ZNF557
Response to unfolded protein
(GO:0006986)
DNAJB6, HSPA1A, HSPH1
Underlined = negative regulator.
MK = MAPK pathway, GO:0000165.
C = cytoskeleton, GO:0005856.
HSP = heat-shock protein.
doi:10.1371/journal.pone.0017509.t002
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analysis. Conidial infection and WT-CF treatment increased
MCP1 mRNA to 10 and 10.9-fold respectively as measured by the
microarrays. A similar, though attenuated response was seen by
RT-PCR analysis. It is important to note that our RT-PCR
microarray validation analyzed only the expression of the two key
cytokines IL8 and MCP1 and did not include genes induced
specifically by WT-CF compared to DPrtT CF.
A. fumigatus CF activates ERK and JNK signaling in A549
cells in a protease-dependent manner
Based on the results of the microarray analysis, we hypothesized
that A. fumigatus germinating conidia or CF activate MAPK
signaling in A549 cells. To test this hypothesis, A549 cells were
incubated in the presence of WT and DPrtT conidia and CFs,
harvested after 0.5, 1, 2 and 3 h and analyzed by western blot with
phospho-specific and protein-specific anti-ERK1/2, p38 and JNK
antibodies. These time points were selected because we reasoned
that kinase phosphorylation occurs rapidly, before the transcrip-
tional and morphological changes seen after 8 h of exposure. As a
control for conidial infection, cells were incubated in the presence
of 2- to 4-mm diameter polystyrene beads. The results indicated
that WT and DPrtT conidia activate some residual ERK signaling
in comparison to the polystyrene beads (Fig. 2A–B). Conidial
infection for up to 6 h (during which time hyphal growth had
begun) did not result in significant MAPK activation (data not
shown). In contrast, WT A. fumigatus CF induced the phosphor-
ylation of ERK1/2, p38 and JNK after 1 to 2 h of incubation.
Interestingly, DPrtT-derived CF did not induce ERK1/2 or JNK
phosphorylation and only partially activated p38 phosphorylation
(Fig. 2C–D). Heat- inactivation of WT-CF proteolytic activity
blocked its ability to activate ERK1/2 or JNK phosphorylation
(Fig. 2E-F). This suggests that in CF-treated A549 cells, ERK and
JNK phosphorylation occurs in response to the proteolytic activity
of secreted fungal proteases or possibly to the activity of additional
proteins secreted in a PrtT-dependent manner.
Inhibition of ERK or JNK signaling partially protects A549
cells from CF-induced cell peeling and loss of viability
We reasoned that CF-induced phosphorylation of ERK, JNK
and p38 kinases in A549 cells plays an important role in
orchestrating later changes in cell morphology and viability. We
therefore preincubated the cells in the presence of ERK1/2, JNK
or p38-specific inhibitors, followed by addition of CF for 12 h.
A549 cells were subsequently analyzed for changes in morpho-
logy, ERK1/2/JNK/p38 phosphorylation and viability. Heat-
inactivation of WT-CF proteolytic activity blocked its ability to
peel the cells. Inhibition of ERK and JNK signaling partially
blocked CF-induced A549 cell peeling, whereas inhibition of p38
kinase activity did not (Fig. 3A). Western blot analysis showed that
the ERK1/2 and JNK inhibitors specifically inhibited CF-induced
ERK1/2 autophosphorylation and c-jun (a direct downstream
target phosphorylated by JNK) phosphorylation, respectively
(Fig. 3B). CF-induced reduction in A549 cell viability, as measured
by the reduction in XTT, was markedly delayed (for up to 16 h)
following incubation of the cells in the presence of the ERK1/2-
and JNK-specific inhibitors (Fig. 3C). At later time points (24 and
36 h incubation in the presence of CF), cell viability was strongly
reduced despite the pretreatment with the inhibitors.
Inhibition of ERK or JNK signaling partially protects A549
cells from CF-induced actin-fiber depolymerization and
necrosis
We previously showed that the proteolytic activity of CF induces
rapid (2–8 h) depolymerization of the actin cytoskeleton in treated
A549 cells, leading to subsequent cell detachment and death [25].
Here, we reasoned that the ERK1/2 and JNK inhibitors might
protect the cells by inhibiting these events. A549 cells were
preincubated for 2 h with control medium or medium containing
JNK or ERK inhibitors, washed repeatedly, and further incubated
for 8 h in the presence of WT or DPrtT-derived CF (Fig. 4A).
Actin fibers were visualized by phalloidin FITC staining and
Table 3. Genes downregulated in response to WT CF treatment.
GENE CATEGORIES Genes downregulated in response to WT CF treatment
Amino acid and derivative metabolism
(GO:0006519)
AARS, AKR1C1, CARS, EPRS, GARS, GCLC, GCLM, GSTA1, IARS, IDH1,
MARS, MTHFD2, PCK2, SARS, SLC3A1, SLC7A7, SLC23A2, TARS, YARS
Nitrogen compound metabolism
(GO:0006807)
ALDH6A1, ASL, ASMTL, ASNS, ASS1, AUH, BCAT1, CBS, CORO2A, CPS1,
HGD, HMOX1, LGSN, MAOA, NAMPT, PHGDH, PSAT1, PSPH, PYCR1
Lipid metabolism
(GO:0006629)
ABCA1, ABCG1, ACACA, ACSM3, ALG13, BDH2, CYP4F3, DHRS3, GDPD5,
HMGCS2, PLA2G6, PLCXD1, PLD1, SCD, SCD5, SREBF1, VLDLR
doi:10.1371/journal.pone.0017509.t003
Table 4. Genes upregulated in response to WT CF vs. DPrtT CF.
GENE CATEGORIES Genes upregulated in response to WT CF vs. DPrtT CF
Cell cycle
(GO:0007049)
ANLN, ASPM, AURKA
C, BARD1, BIRC5, BUB1, BUB1B
C, CCNA2, CCNB1, CCNB2, CDC2, CDC25, CDCA2, CDCA3, CDCA5, CDK6, CDKN3,
CENPF, CEP55, CIT, CHTF8, CKAP2, CKAP5
C, DBF4B, DCDC2, DLGAP5, DUSP6, ECT2, EDN1, ENC1, EPB41L2, ESCO2, GADD45A, GAS2L3,
GINS1, GTSE1
C, INCENP, KIF11
C, KIFF14
C, KIF23
C, KIF2C
C, KIF4A
C, KIF18B
C, KIF20A
C, KIFC1
C, LMNB1, NCAPG, NGAG2, NCAPH, NUF2,
NUSAP1
C, PLK2, PBK, PRC1
C, PTTG1, RACGAP1, RGS2, SPAG5
C, STMN1
C, TACC3, TPX2, TXNIP, UBE2C
C, ZWILCH
Unfolded protein response
(GO:0006986)
ASF1B, HSPH1,HSPA1A, HSPA1B, HSPA4L, HSP90AA1, DNAJA1/HSP40, DNAJB1/HSP40,
HSPA6/HSP70B, DNAJB4/HSP40, SERPINH1
Underlined: genes containing NF-Y promoter binding sites.
C = Cytoskeleton (microtubule) GO:0015630.
doi:10.1371/journal.pone.0017509.t004
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did not affect actin-fiber polymerization (data not shown). WT CF
caused actin-fiber depolymerization whereas DPrtT CF did not.
Interestingly, treatment with JNK or ERK1/2 inhibitors blocked
WT-CF-induced actin-fiber depolymerization and cell rounding,
suggesting that these processes are dependent on JNK or ERK1/2
activity.
Previous studies have indicated that CF-treated A549 cells die
mainly by necrosis, with some cells initiating apoptosis but
ultimately also undergoing necrosis [23,25]. To determine
whether the JNK or ERK1/2 inhibitors delay CF-induced A549
necrosis or apoptosis, cells were pretreated with the inhibitors as
described above and incubated for 12 h in CF. The cells were
harvested, stained with PI (necrosis) and annexin-V-FITC
(apoptosis) and analyzed by flow cytometry. Results showed that
WT CF and DPrtT CF induce necrotic death in 89% and 6% of
the cells, respectively, suggesting that necrosis is primarily
mediated by PrtT-regulated secreted proteins, possibly including,
fungal proteases (Fig 4B). Interestingly, preincubation of the cells
with ERK1/2- or JNK-specific inhibitors inhibited necrosis to
11% and 18% of the cells, respectively (Fig. 4B). These results
imply that CF-induced cell necrosis is dependent on both PrtT-
regulated secreted proteins and the subsequently activated JNK or
ERK1/2 signaling in the exposed cells.
Discussion
We describe the transcriptional response of cultured A549 lung
epithelial cells to infection by A. fumigatus germinating conidia or
treatment with CF. We show that CF induces MAPK (ERK1/2,
JNK, p38) phosphorylation in treated A549 cells in a PrtT-
dependent manner. PrtT is a key A. fumigatus transcription factor
regulating the expression of secreted proteases [26,27]. Inhibition
of ERK1/2 or JNK activity partially protected the cells from CF-
induced damage, suggesting that these kinases are an important
component in the induction of cell peeling, loss of actin fibers and
necrosis.
The transcriptional response of A549 lung epithelial cells
to A. fumigatus conidial infection or exposure to CF
We chose to compare both conidial and CF models of cell
exposure because germinating conidia represent the earliest phase
of infection, whereas CF may partly recapitulate aspects of late
infection, such as the secretion of enzymes and toxins by a
Table 5. Genes downregulated in response to WT CF vs. DPrtT CF.
GENE CATEGORIES Genes downregulated in response to WT CF vs. DPrtT CF
Signal transduction
and cell communication
(GO:0010646)
ABCA1
T, ABLIM3
c, ABR, ACVR1, AGAP6, AP4M1
T, ARAF, ARAP3
c, ARNT, ARFGAP3
c, ARHGAP5
c,ARHGAP32
c, ARHGEF3
c, ARL4D
T,
BAIAP2L1
c, BCAR3, BDKRB1, BDKRB2, BMP6, CLN8
T, CORO2B
c, CTNNB1
c, CYTH2
c, DAPK2, DNMPB
c, DUSP10, EXOC2
T, FHL3
c, F2R,
F2RL1, GARNL3, GPR56, GREM1, GRK5, GSN
c, HOOK2
c, HTR1D, IL11, IL4R, IL17RA, IRAK2, ITGA2, ITGA4, ITGA5, ITGA11, KCNAB2
T, KCNN4
T,
KCTD21
T, LIF, LITAF, LRP4
T, LRRN2, LYST
T, MLPH
c, MAP1S
c, MAP3K14, MAPK7, MAP7
c, MRAS, MRC2
T, MTSS1
c, MYO9B
c, NHEDC2
T,
NPAS, NPC1
T NPR2, ORC6L, PACS1
T, PDGFA, PITPNC1
T, PITPNM
T, PLAUR, PLA2R1,PLCB1, PLCG1, PLEK2
c, PLEKHG2, PLEKHM1, PPARD,
PREX1
c, PSD3, PTPRK, PYARD, RAB31
T, RAB43
T, RAB7L1
T, RALGAPA2, RAP1GAP
T, RAP1GAP2
T, RASA2, RASA3, RASA4, RASEF
T, RASGRP1,
RASGRP3, RHOBTB2, RHOU
c, RIPK1, RND1
c, SFRP, SH2B2, SH3KBP1
c, SIPA1L2, SLC14A1
T, SLC17A5
T, SLC19A3
T, SLC20A1
T, SLC22A23
T,
SLC2A13
T, SLC6A16
T, SPHK1, SPSB1, SQSTM1, STK38L, STX1A
T, STX4
T, SYNRG
T, SYT13
T, TBC1D25, TBC1D3B, TCIRG1
T, TGFB1, TGFB2,
TGFBR1, TMOD1
c TNFRSF1A, TOM1
T, ULK1, VEGFA, VPS41
T, WIPF1C
c
C = cytoskeleton, GO:0007010.
T = transport, GO:0006810.
Underlined: genes containing MOVO-B promoter binding site.
doi:10.1371/journal.pone.0017509.t005
Figure 1. Validation of changes in cytokine gene expression levels. A549 cells were grown with either WT conidia or WT-CF for 8 h. Control
cells had no added fungi or CF. RT-PCR was used for semi-quantitative analysis of IL-8 and MCP1 transcripts. IL8 levels showed a 16-fold rise in
response to conidial infection (black) and a 6-fold increase in response to WT CF (grey). Conidial infection and WT-CF treatment activated MCP1
transcription to similar levels (approximately 3-fold) as measured by the microarrays. Data are presented as mean 6 SD.
doi:10.1371/journal.pone.0017509.g001
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infecting cells for an extended period with germinating conidia,
because they form a hyphal mass which cannot be separated from
the cells.
A549 cells responded to conidial infection by activating genes
characteristic of a prototypical ‘‘host core alarm response’ pre-
viously shown to be induced in epithelial cells infected by viruses
or bacteria [33,34]. This includes the activation of genes encoding
cytokines, initiating inflammation, and activating the NFkB and
MAPK/AP-1 (jun/fos) signaling pathways, as well as genes that
limit the immune response such as NFkBIA, TNFAIP3 and the
DUSP-MAPK-phosphatases. In marked contrast, WT-CF treat-
ment of A549 cells induced a transcriptional response character-
ized by a reduction in the mRNA levels of genes involved in amino
acid/lipid metabolism and protein translation. This suggests that
CF treatment damages the cells, shutting down the transcription of
genes involved in vital cell functions. WT CF increased the mRNA
levels of genes involved in signal transduction and in particular the
MAPK pathway, as well as genes involved in regulating
cytoskeletal changes. Indeed, both processes are strongly affected
in CF-treated cells (see proceeding sections).
Interestingly, conidial infection activated more cytokine-encoding
genes than the WT CF treatment. This could reflect the fact that the
conidia physically interact with the infected cells. This interaction
involves binding of conidial surface polysaccharides by cellular pattern
recognition receptors, activating a strong cytokine response [12,35].
A comparison of the A549 cells’ responses to treatment with
WT CF and DPrtT CF showed several differences: WT CF, unlike
Figure 2. Phosphorylation of ERK1/2, JNK, and p38 is activated by WT CF. A549 cells were treated for 30 min, 1 h, 2 h or 3 h with (A–B) WT
or DPrtT conidia, or inert polystyrene beads, (C–D) WT CF or DPrtT CF (lacking protease activity) or for 3 h with (E-F) WT-CF and heat-inactivated (HI)
CF lacking protease activity. We used hydrogen peroxide (H2O2)-treated cells as a positive control (+), and carrier-treated cells as a negative control
(2). Phosphorylation of ERK1/2, JNK, and p38 was monitored by western blotting of whole-cell extracts with specific anti-p-ERK (Thr183/Tyr185),
anti-p-SAPK/JNK (Thr183/Tyr185), and anti-p-p38 (Thr180/Tyr182) MAPK antibodies (A, C, E). Total MAPK levels were monitored by ERK1/2, JNK and
p38-specific antibodies (B, D, F).
doi:10.1371/journal.pone.0017509.g002
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PLoS ONE | www.plosone.org 7 March 2011 | Volume 6 | Issue 3 | e17509Figure 3. MAPK inhibitors protect A549 lung epithelial cells from loss of viability induced by CF treatment. (A) ERK1/2 and JNK
inhibitors block CF-induced cell peeling. A549 cells pretreated for 2 h with 50 mM ERK-I (FR180204), 25 mM JNK-I (SP600125) or 25 mM p38-I
(SB203580) washed, incubated for 12 h in the presence of WT CF, stained with hemacolor and analyzed by microscopy (bar =100 mm for all images).
Cells pretreated with ERK-I or JNK-I remained attached to the plate and retained their elongated shape. Cells treated with heat-inactivated WT CF
lacking protease activity retained their normal shape (B) Verification of ERK1/2 and JNK inhibitor specificity. A549 cells pretreated with ERK-I, JNK-I or
p38-I were washed, incubated with WT CF for 3 h, lysed and analyzed by western blot with ERK1/2 and c-Jun-specific antibodies. (C) ERK1/2 and JNK
inhibitors block CF-induced cell death. A549 cells pretreated with ERK-I (grey), JNK-I (unshaded) or a carrier control (black) were washed and
incubated with WT CF for 12, 16, 24 or 36 h. Cell viability was determined by the XTT colorimetric assay which measures mitochondrial metabolic
activity. Shown are the means standard deviations (error bars) for three independent experiments. *, P value of ,0.05 for cell viability following
inhibitor treatment relative to untreated cells at the same time-point.
doi:10.1371/journal.pone.0017509.g003
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control and the UPR. The UPR is activated in response to the
accumulation of unfolded or misfolded proteins in the lumen of the
endoplasmic reticulum, and involves the arrest of protein synthesis
and the cell cycle and upregulation of proteins involved in
chaperoning misfolded proteins and protein folding [36]. Activa-
tion of the UPR might be attributable to the activity of secreted
proteins, including proteases found in the WT CF and not in the
DPrtT CF.
PrtT-regulated proteins secreted by A. fumigatus induce
JNK, ERK1/2 and p38 phosphorylation in exposed A549
cells
A. fumigatus WT CF rapidly induced phosphorylation/activation
of JNK, ERK1/2 and p38 in A549 cells, whereas infection of the
cells with germinating conidia did not. CF-induced phosphoryla-
tion of ERK1/2 and JNK was dependent on the presence of PrtT-
regulated secreted proteins, including proteases, as it did not occur
when heat inactivated WT-CF or CF from a PrtT-deficient strain
of A. fumigatus was added to the cells.
The MAPKs JNK, ERK1/2 and p38 are activated by phosph-
orylation induced by various mitogens and cell stressors, including
osmotic stress, heat shock and proinflammatory cytokines. They
regulate diverse cellular activities, such as gene expression, mitosis,
differentiation, cytoskeletal rearrangement, proliferation and apop-
tosis [37]. MAPK activation also occurs in cells infected by various
pathogens, including viruses [38,39,40], bacteria [41,42,43] and
some fungi [9,44,45,46,47,48]. Interestingly, specific MAPK
inhibitors can, in some cases, block the entry or proliferation of
the infecting virus or bacteria in infected cells [39,41,43]. In
contrast,inhibition of ERK signaling inmacrophagesorneutrophils
infected with Candida albicans has been shown to impair these cells’
ability to migrate toward and kill the fungus [46,48,49]. Relatively
little is known about the role of host-cell MAPKs in response to A.
fumigatus infection. Infection of the human bronchial epithelial cell
line BEAS-2B with germinating A. fumigatus conidia resulted in
phosphorylation of both ERK1/2 and p38 and subsequent release
ofIL8[9].Incontrast,inthiswork,MAPKphosphorylationwasnot
specifically induced by germinating A. fumigatus conidia, reflecting a
possible difference in the response of the A549 human alveolar type
II cell line used in this study and that of the BEAS-2B line [9]. Here,
we show for the first time that A. fumigatus CF induces PrtT-
dependent JNK, ERK1/2 and p38 phosphorylation in treated
A549 cells. Since deletion of PrtT results primarily in the loss of
secreted protease activity, it is likely that this activity may be
responsible for the subsequent MAPK activation in the treated
A549 cells [49]. Secreted proteases have been shown to cleave and
activate A549 cell-surface receptors, subsequently activating
downstream signaling elements, including the MAPK cascade.
For example, proteolytic activation of the PAR-2 receptor in lung
epithelial cells has been shown to result in a strong inflammatory
response characterized by the release of proinflammatory cytokines,
prostaglandins and leukocyte recruitment [50]. A549 cells express
PAR-2, and its proteolytic activation by the dust mite serine
protease allergen Der p 3 results in the activation/phosphorylation
of ERK1/2 and release of IL8. Interestingly, this response can be
blocked by the addition of ERK1/2 inhibitors [51,52].
Inhibition of JNK or ERK1/2 activity in CF-exposed A549
cells partially protects them from damage and death
induced by A. fumigatus CF
We show that addition of JNK or ERK1/2 inhibitors, but not
p38 inhibitors, to A549 cells treated with WT CF markedly delays
(i) loss of cell adhesion and viability as measured microscopically
and by the XTT cell viability assay, [11] depolymerization of actin
fibers and subsequent cell rounding as measured by actin
fluorescence staining, and (iii) necrotic cell death as quantified
by annexin V/PI staining and flow cytometry.
Treatment with these inhibitors increased the survival time of
treated cells from 6–12 h (untreated) to 16–24 h (treated with JNK
or ERK1/2 inhibitors). Previous work has shown that ERK1/2
and p38 inhibitors can block the inflammatory response of human
bronchial epithelial cells infected by germinating A. fumigatus
conidia [9], but to the best of our knowledge, this is the first time
that MAPK inhibitors have been shown to produce an overall
protective response in cells treated with fungal CF. Our results
suggest that some of the damage occurring in the cells in response
to CF is self-inflicted: PrtT-regulated secreted proteins, likely
including proteases induce A549 cell MAPK signaling which
promotes pathways that actively lead to loss of actin fibers, cell
rounding and ultimately, necrotic death. We previously demon-
strated similar partial protection of A549 cells treated with WT CF
in the presence of protease inhibitors [25]. In both cases, only
partial protection suggests that in addition to proteases, other
fungal-secreted components, such as gliotoxin, are involved in this
process. The partial protection we observed in vitro may also
explain why the A. fumigatus PrtT deletion mutant exhibits
apparently normal virulence in infected mice [26,27]: since
invasive aspergillosis is a multifactorial infection, lack of protease
activity in this fungus may be masked by additional virulence
mechanisms. Additionally the mouse model uses a very large
conidial inoculum for infection and may not be sufficiently subtle
to detect small differences in virulence. Our results suggest,
however, a possible therapeutic approach in which A. fumigatus
infection is treated by a combination of antifungals and MAPK
inhibitors which can modulate an excessive host inflammatory
response [37,53]. Indeed, tissue necrosis in steroid-treated non-
neutropenic IPA is primarily mediated by inflammatory neutro-
philic and monocytic infiltrates [54].
In summary, we carried out an initial characterization of the
signaling and transcriptional events occurring in a lung alveolar
cell line exposed to A. fumigatus germinating conidia and CF and
identified the important role of MAPK signaling in the cellular
response. Future work will focus on the identification of the signal-
transduction pathways mediating MAPK activation in the CF-
treated cells. We will also test the applicability of treating steroid-
dependent IPA in a mouse model with a combination of
antifungals and MAPK inhibitors.
Figure 4. ERK1/2 and JNK inhibitors block CF-induced actin-fiber depolymerization and necrotic death. A549 cells pretreated with ERK-
I, JNK-I or p38-I were washed and incubated with WT CF for 8 h. Cells treated with DPrtT CF (lacking protease activity) or carrier (untreated) served as
negative controls. Cells were (A) stained for actin with phalloidin-FITC and analyzed by confocal microscopy. Cells treated with ERK-I or JNK-I retained
their flattened shape and network of actin fibers. (bar =20 mm for all images) whereas cells treated with p38-I did not (B) assayed for apoptosis/
necrosis by flow cytometry following annexin V (x-axis)/PI staining (y-axis) of the cells. WT CF induces protease-dependent cellular necrosis whichi s
blocked by ERK1/2 and JNK inhibitors. Upper panel: necrosis is induced in A549 cells after 12 h of incubation in the presence of WT CF but not DPrtT
CF. Lower panel: ERK-I and JNK-I inhibit the induction of necrosis in A549 cells under WT CF treatment. Experiments were repeated three times with
similar results. A representative experiment is shown.
doi:10.1371/journal.pone.0017509.g004
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